Ujjivan Small Finance Bank Ltd
₹56.70
-0.10 (0.18%)
Fri, 06 Nov 2026, 08:56 pm
Ujjivan Small Finance Bank News
Ujjivan SFB Head of Internal Audit retires
Vijayalakshmi Muddu, Head of Internal Audit at Ujjivan Small Finance Bank, voluntarily retired effective October 30, 2026, citing personal reasons.
30 Oct 2026
companies
Ujjivan SFB to host investor meet Oct 30
Ujjivan Small Finance Bank will hold an in-person investor meeting with Flowering Tree Investment on October 30, 2026, in Bengaluru.
27 Oct 2026
companies
Ujjivan SFB plans ₹409 crore preferential issue
Ujjivan Small Finance Bank will seek shareholder approval for a ₹409.04 crore preferential issue to IFC and three insurers, aiming to strengthen capital adequacy.
19 Oct 2026
companies
Ujjivan SFB Q2 revenue up 28% YoY; asset quality stable
Ujjivan Small Finance Bank reported Q2 revenue of ₹21.5 billion, up from ₹16.8 billion YoY. Gross NPA held steady at 2.1%, while Net NPA improved slightly to 0.31%.
16 Oct 2026
companies
Ujjivan SFB Q2FY27: Deposits up 29%, loans jump 32%
Ujjivan Small Finance Bank reported strong Q2FY27 growth with deposits rising 29.2% YoY to ₹50,649 crore and gross loans up 32.1% to ₹45,699 crore, driven by MSME and housing segments.
03 Oct 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo